Third Rock Ventures is participating in the diabetes-obesity Keystone Symposium co-sponsored by the Endocrine Society.

Public source

Publisher name

Public post

Get ready to join in a very special diabetes-obesity Keystone Symposium (co-sponsored by the Endocrine Society) - our focus is on: basic science breakthroughs; translati…

Log in to read the full post

Company

Third Rock Ventures

Industry
Venture Capital and Private Equity Principals
Location
Boston, US
Company size
51–200 employees

About Third Rock Ventures

We discover, launch and build great companies based on bold ideas that meet at the intersection of science, strategy, business and medicine – where transformational science meets operational reality – providing the best opportunity to make a dramatic difference in patients’ lives. THE THIRD ROCK TEAM Our team has a proven record of translating disruptive technologies into valuable business enterprises. Working closely with leading scientific and business visionaries as well as industry partners, we identify opportunities to change the future of medicine and rigorously vet those ideas through our discovery process to develop the vision, strategy and plan needed to succeed. A FORMULA FOR INNOVATION We only invest in the best of those ideas. We are actively involved in the early stages of our companies’ development, typically serving as members of the founding management teams, to build a strong foundation, put in place the right people and culture, and set the companies on a path to scientific and operational excellence. We believe in the companies we launch and make big initial investments, often complemented by strategic alliances, to enable our companies to advance life-changing therapies, devices and diagnostics. By creating value for patients, we create value for our investors.

See more

Latest activity

3 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.